For the quarter ended 31 December 2022, KPJ Healthcare recorded RM780.9 million in revenue, an increase of 15% from RM680.8 million reported in the corresponding quarter in December 2021.
During the quarter under review, patient visits and bed occupancy rate (“BOR”) increased to 820,734 patients from 780,221 patients and 64% from 46% respectively.
The Group recorded a total EBITDA of RM202 million, an increase of 43% from RM141 million reported in the previous corresponding quarter. Profit before tax for the current quarter totalling RM90.5 million, was higher by more than 100% as compared to RM41.5 million recorded in the previous corresponding quarter mainly driven by the improved performance from the Malaysia segment.
The Malaysia segment was the main contributor with revenue of RM753.1 million, representing 96% of Group revenue, higher than RM655.5 million reported in the corresponding quarter ended 31 December 2021. As compared to previous corresponding quarter, total patient visits for the quarter were 775,763, an increase of 3% from 755,282 while the BOR recorded at 63% against 47% contributed by the increase in inpatient days.
The segment recorded higher EBITDA of RM207.0 million, an increase of 40% from RM147.4 million reported while the PBT was RM104.0 million, an increase of 86% as compared to RM55.9 million recorded in the previous corresponding quarter.
During the quarter, the segment also recorded a reversal of impairment in property, plant and equipment (“PPE”) amounting to RM6.7 million in contrast of impairment loss of RM14.1 million relates to PPE and intangible assets recorded in Q4 2021.
For the financial year ended 31 December 2022, the Group recorded RM2,920.7 million in revenue, an increase of 13% from RM2,589.9 million reported in the preceding financial year at the back of growing hospital activities, evidenced by increase in patient visits to 3,263,832 patients (2021: 2,976,018 patients) and BOR of 58% (2021: 43%).
In line with increase in revenue, coupled with improved cost management practices, EBITDA for the current financial year was 34% higher at RM708.8 million as compared to RM528.3 million for the financial year ended 31 December 2021. Accordingly, the profit before tax stood higher at RM263.5 million as compared to 2021 of RM121.2 million
